Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients
1999
L-myc Gene and Bladder Cancer Prognosis
Sample size: 98
publication
Evidence: low
Author Information
Author(s): Ejarque M J, Vicente M, Bernués M, Oliver A, Vicente J, Capellá G, Lluís F, Chéchile G
Primary Institution: Fundació Puigvert, Barcelona, Spain
Hypothesis
Does the L-myc genotype have prognostic significance in bladder cancer patients?
Conclusion
The L-myc genotype does not correlate with any pathologic parameter and offers no clinical utility in bladder cancer patients.
Supporting Evidence
- The L-myc genotype was examined in 98 bladder cancer patients.
- No correlation was found between the L-myc genotype and any pathologic parameter.
Takeaway
Scientists looked at a gene to see if it could help predict how bladder cancer would affect patients, but it turns out it doesn't help at all.
Methodology
Examined the L-myc genotype in a group of bladder cancer patients.
Participant Demographics
Bladder cancer patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website